The Genomic Gateway: How Rising Cancer Incidence and Personalized Medicine Adoption are Fueling the DNA Microarray Market to a $3.9 Billion Valuation
Description: This article examines the enduring relevance and growth drivers of the DNA Microarray Market, focusing on its essential role in gene expression analysis, cancer research and detection, drug discovery, and its expected growth to nearly $\$4$ billion by 2030 despite competition from newer sequencing technologies.
Blog Post 1/1
Despite the rise of Next-Generation Sequencing (NGS), the DNA Microarray Market maintains a strong and growing presence in the life sciences and clinical research landscape. Valued at nearly $\$2$ billion in 2023, the market is projected to reach $\$3.93$ billion by 2030, advancing at a steady CAGR of 10.5%. This persistent growth is largely attributed to the technology’s high-throughput capacity, cost-effectiveness for targeted assays, and its crucial application in gene expression profiling.
The largest application segment driving this growth is Cancer Research and Diagnostics.…
